Annual Shareholders Equity
$332.21 M
+$54.79 M+19.75%
31 December 2023
Summary:
Keros Therapeutics annual stockholders equity is currently $332.21 million, with the most recent change of +$54.79 million (+19.75%) on 31 December 2023. During the last 3 years, it has risen by +$70.49 million (+26.93%). KROS annual shareholders equity is now at all-time high.KROS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$532.84 M
+$111.92 M+26.59%
30 September 2024
Summary:
Keros Therapeutics quarterly stockholders equity is currently $532.84 million, with the most recent change of +$111.92 million (+26.59%) on 30 September 2024. Over the past year, it has increased by +$236.99 million (+80.11%). KROS quarterly shareholders equity is now at all-time high.KROS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.8% | +80.1% |
| 3 y3 years | +26.9% | +143.9% |
| 5 y5 years | +2504.0% | - |
KROS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.6% | at high | +152.3% |
| 5 y | 5 years | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Keros Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $532.84 M(+26.6%) |
| June 2024 | - | $420.92 M(-7.3%) |
| Mar 2024 | - | $453.95 M(+36.6%) |
| Dec 2023 | $332.21 M(+19.7%) | $332.21 M(+12.3%) |
| Sept 2023 | - | $295.84 M(-9.3%) |
| June 2023 | - | $326.26 M(-8.1%) |
| Mar 2023 | - | $354.98 M(+28.0%) |
| Dec 2022 | $277.42 M | $277.42 M(+15.1%) |
| Sept 2022 | - | $241.03 M(+14.1%) |
| June 2022 | - | $211.21 M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $223.49 M(-8.1%) |
| Dec 2021 | $243.17 M(-7.1%) | $243.17 M(+11.3%) |
| Sept 2021 | - | $218.48 M(-7.3%) |
| June 2021 | - | $235.66 M(-5.1%) |
| Mar 2021 | - | $248.37 M(-5.1%) |
| Dec 2020 | $261.72 M(>+9900.0%) | $261.72 M(+100.2%) |
| Sept 2020 | - | $130.76 M(-7.5%) |
| June 2020 | - | $141.36 M(+178.0%) |
| Mar 2020 | - | $50.85 M(>+9900.0%) |
| Dec 2019 | $495.00 K(-96.1%) | $495.00 K |
| Dec 2018 | $12.76 M | - |
FAQ
- What is Keros Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Keros Therapeutics?
- What is Keros Therapeutics annual shareholders equity year-on-year change?
- What is Keros Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Keros Therapeutics?
- What is Keros Therapeutics quarterly shareholders equity year-on-year change?
What is Keros Therapeutics annual stockholders equity?
The current annual shareholders equity of KROS is $332.21 M
What is the all time high annual shareholders equity for Keros Therapeutics?
Keros Therapeutics all-time high annual stockholders equity is $332.21 M
What is Keros Therapeutics annual shareholders equity year-on-year change?
Over the past year, KROS annual stockholders equity has changed by +$54.79 M (+19.75%)
What is Keros Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of KROS is $532.84 M
What is the all time high quarterly shareholders equity for Keros Therapeutics?
Keros Therapeutics all-time high quarterly stockholders equity is $532.84 M
What is Keros Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, KROS quarterly stockholders equity has changed by +$236.99 M (+80.11%)